{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-016824","form_type":"8-K","ticker":"LENZ","cik":"0001815776","company_name":"LENZ Therapeutics, Inc.","filed_at":"2025-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.841217+00:00","generated_at":"2026-05-23T21:18:05.540969+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"LENZ Therapeutics enters into $150M ATM sales agreement with TD Cowen","bullets":["Company entered Sales Agreement with TD Securities (USA) LLC to sell up to $150M common stock via ATM offering.","TD Cowen will act as sales agent and receive up to 3.0% of gross proceeds from shares sold.","Shares will be issued under shelf registration statement on Form S-3 filed April 4, 2025.","Company has no obligation to sell shares and may suspend offerings at any time.","Agreement can be terminated by either party on 10 days' notice or immediately under certain conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-016824","json":"https://secwatch.observer/filing/0001628280-25-016824.json","markdown":"https://secwatch.observer/filing/0001628280-25-016824.md","text":"https://secwatch.observer/filing/0001628280-25-016824.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815776/000162828025016824/0001628280-25-016824-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815776/000162828025016824/lenz-20250404.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T21:18:05.540969+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}